Crossmark

Optimal EPO dosing in hemodialysis patients using a non-linear model predictive control approach

Published Online: 2019-10-19

Published Print: 2019-12

Authors

Rogg, S. https://orcid.org/0000-0002-9083-4329
Fuertinger, D. H.

Volkwein, S.

Kappel, F.

Kotanko, P.
Funding

Funding for this research was provided by:

Renal Research Institute New York, New York, USA
License Information

Text and Data Mining valid from 2019-10-19

Version of Record valid from 2019-10-19
More Information

Article History

Received: 13 January 2018

Revised: 6 September 2019

First Online: 19 October 2019

Document is current